Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
5
×
national blog main
national top stories
abbvie
biotech
clinical trials
fda
boston blog main
boston top stories
eli lilly
new york blog main
allergan
drugs
europe blog main
merck
national
new york top stories
san diego blog main
san diego top stories
4d molecular therapeutics
acne
acorda therapeutics
agenus
alkermes
amgen
ampyra
apokyn
apomorphine
astrazeneca
auris health
avexis
bayer
biohaven
biomx
bladder cancer
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
broad institute of mit and harvard
buprenorphine
What
fda
5
×
treatment
5
×
approved
drug
disease
medicine
new
nod
acorda
adults
alkermes
allergan
antipsychotic
benefits
bio
caveats
cells
class
cleared
clinical
commonly
companies
company
cope
cosmeceutical
designed
diego’s
digital
effect
epidemic
episodes
fatty
favor
female
frenzied
friday
gain
gets
gi
growing
Language
unset
Current search:
fda
×
treatment
×
" life sciences "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Histogen Treatment for Female Hair Loss Cleared for Clinical Testing